Welcome to Santorini Conferences series Association (SCs)

Lorem ipsum proin gravida nibh vel veali quetean sollic lorem quis bibendum nibh vel velit.

Evently

Stay Connected & Follow us

Fira, 84700 Santorini, Greece

Simply enter your keyword and we will help you find what you need.

What are you looking for?

Good things happen when you narrow your focus
Welcome to Conference

Write us on info@santorniconference.org

Follow Us

Count Every Second Until The Event.

Welcome Letter from

Dr. Sofia Siest

Dear colleagues, Dear friends,

It is with great pleasure that I announce The 10+2 Santorini Conference to be held from May 26 to 29, 2026 in Santorini!!!

I am full of emotion because 24 years after its creation still the journey continues! Our passion and determination are always present as a tribute to this endeavor and a commitment to never stop.

The appreciation you show, in our efforts to keep the Santorini Conferences active and interact through these events, makes us enthusiastic and at the same time increases our responsibility towards All of you.

Based on the history and tradition of the previous Conference, The 10+2 Santorini Conference, SYSTEMS MEDICINE AND PERSONALISED HEALTH & THERAPY – The Odyssey from Hope to Practice: “Patient first – keep Ithaca always in your mind”, is using as metaphor the Greek mythology to resolve and overcome the thematic obstacles of personalised medicine for the benefit of the patient.

The 10+2 Santorini Conference will be once again a high standard Conference, full of events and presentations of cutting-edge work on Personalised Medicine.

Together with a Steering Committee (SC) and a Scientific Advisory Board (SAB) composed by members across academia, clinics and industry, The 10+2 Santorini Conference is aiming to create interactions among disciplines, as well as exchanges between basic, industrial and medical research directed around a scientific content towards an effective ‘roadmap’ for personalised health and therapy.

We will be awarding the 2 best Posters (Gerard SIEST Awards) of 500 euros each and selected Oral Communications will make part of the scientific programme.

We count on you for having together valuable and enjoyable moments under the nice sun that fosters an even more creative atmosphere, to “keep Santorini always in your mind”!!!

 

Sofia SIEST,

– President of the Santorini Conferences (SCs) association – For Research Innovation in Health

– President of the Santorini Conferences series

Siest Sofia, Bernécourt, France

  • Siest Sofia, Bernecourt, France – President 
  • Fitzgerald Peter, Randox, Antrim, United Kingdom 
  • Lamont John, Randox, Antrim, United Kingdom   
  • Haushofer Alexander, Wels, Austria 
  • Haliassos Alexandros, Athens, Greece 
  • Kanoni StavroulaLondon, United Kingdom 
  • Siest Sofia, Bernecourt, France – President 
  • Adeli KoshrowToronto, Ontario, Canada 
  • Alix-Panabieres Catherine, Montpellier, France 
  • Alizadeh Behrooz, Gröningen, The Netherlands 
  • Bernardini Sergio, Rome, Italy 
  • Bonnefond Amelie, Lille, France 
  • Boyer Jean Christophe, Nimes, France 
  • Dagher Georges, Paris, France  
  • Deloukas Panos, London, United Kingdom 
  • Dimitrijevic Sreckovic Vesna, Belgrade, Serbia 
  • Eliopoulos Aristides, Athens, Greece 
  • Griesmacher Andrea, Innsbrück, Austria 
  • Haliassos Alexandros, Athens, Greece 
  • Haushofer Alexander, Wels, Austria 
  • Hizel Perry Candan, Montreal, Canada 
  • Iaccino Enrico, Catanzaro, Italy 
  • Kanoni Stavroula, London, United Kingdom 
  • Le FerrierSanta Clara, United States 
  • Marelli-Berg Federica, London, United Kingdom 
  • Marschler Michael, Henstedt-Ulzburg, Germany 
  • Murray Helena, Antrim, United Kingdom  
  • Oram RichardExeter, United Kingdom 
  • Paré Guillaume, Hamilton, Canada  
  • Quemeneur Eric, Paris, France 
  • Rocchiccioli Silvia, Pisa, Italy 
  • Stankovic Sanja, Belgrade, Serbia 
  • Van Schaik Ron, Rotterdam, The Netherlands 
  • Weryha Georges, Nancy, France 
  • Zima Tomas, Prague, Czech Republic 
  • Kanoni StavroulaLondon, United Kingdom – President  
  • Le Ferrier, Santa Clara, United States  
  • Siest Sofia, Bernecourt, France – President 
  • Kanoni Stavroula, London, United Kingdom 
  • Weryha Bernadette, Nancy, France 
  • Petrelis Alexandros, Nice, France 
  • Kokkoni Elisavet, Nice, France 

Steering Committee (SC)

Director of Research in INSERM for 24 years, President of the Santorini Conferences Association (SCs) and of the “Santorini Conferences series”, Founder & Coordinator of the VEGF Consortium, Bernecourt, France

Founder and Managing Director of Randox Laboratories, Antrim, United Kingdom

MD, PhD, EurSpLM, President and CEO of DIAMEDICA PC, Scientific Director of ESEAP - Non profit Greek External Quality Assessment Scheme for Clinical Laboratories, IFCC Treasurer, Athens, Greece

MD, Head of the "Institut für Medizinische und Chemische Labordiagnostik/Central Laboratory”, Klinikum Wels-Grieskirchen, Upper Austria, Austria, Past President of the Austrian Society for Laboratory Medicine and Clinical Chemistry – ÖGLMKC, Wels, Austria

Associate Professor in Nutrigenetics and Cardiovascular Health, Queen Mary University of London, London, United Kingdom

Chief Scientist at Randox and also a Senior Manager, Antrim, United Kingdom

Scientific Advisory Board (SAB)

Director of Research in INSERM for 24 years, President of the Santorini Conferences Association (SCs) and of the “Santorini Conferences series”, Founder & Coordinator of the VEGF Consortium, Bernecourt, France

MD, PhD, EurSpLM, President and CEO of DIAMEDICA PC, Scientific Director of ESEAP - Non profit Greek External Quality Assessment Scheme for Clinical Laboratories, IFCC Treasurer, Athens, Greece

Director of Research in INSERM at the INSERM/CNRS 1283/8199-unit, Lille Pasteur Institute and University of Lille, head of team “Metabolic functional (epi)genomics and their abnormalities in type 2 diabetes and related disorders”, scientific director of the PIA-funded EquipEx LIGAN-PM platform for next-generation sequencing in precision medicine, Lille, France

University Hospital of Nîmes, France. Head of the Toxicology Unit of the Biochemistry and Molecular Biology Department. one of the founders of the French-speaking Pharmacogenetic Network (RNPGx), Nîmes, France

PharmD, Previously, excecutive vice-President in TRANSGENE, currently, Inserm - leader of France Vaccins, Paris, France

Director, R&D, Genetic Sciences Group Thermo Fisher Scientific, Santa Clara, United States

Emeritus Senior Researcher at the National Institute for Health and Research, (Inserm, Paris), visiting Professor at Graz Medical University, Austria, Visiting Professor at Faculty of Medicine, Milano-Bicocca University, Italy, Honorary professor at Stem Laboratory, Chinese Academy of Sciences, Beijing, Paris, France

Team Leader in Molecular Diagnostics at Randox, Antrim, United Kingdom

Assoc. Director, Precision Medicine & Omics Platforms, CRCHUM - Université de Montréal, Montreal, QC, Canada

Senior Researcher of Italian National Research Council, Rome – CNR, Pisa, Italy

Henstedt-Ulzburg, Germany

MD, Head of the "Institut für Medizinische und Chemische Labordiagnostik/Central Laboratory”, Klinikum Wels-Grieskirchen, Upper Austria, Austria, Past President of the Austrian Society for Laboratory Medicine and Clinical Chemistry – ÖGLMKC, Wels, Austria

MD, Professor in Oncology, Faculty of Medicine, Director of the Liquid Biopsy Laboratory, CHU, Montpelier, France

MD, Professor at University Hospitals of Innsbruck, President of the Austrian Association for Quality Assurance and Standardization of Medical and Diagnostic Tests (ÖQUASTA), Innsbruck, Austria

Professor of Biology & Genetics and Head of the Department of Biology at the National & Kapodistrian University of Athens (NKUA), School of Medicine. Co-founder of the NKUA spin-off company “GENOSOPHY”, Athens, Greece

MD, genetic epidemiology at UMCG Groningen, CHARGE, Groningen, Gröningen, The Netherlands

Associate Professor in Clinical Biochemistry, University “Magna Graecia” of Catanzaro, Catanzaro, Italy

MD, PhD, BHF Chair of Cardiovascular Immunology, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London (QMUL), London, United Kingdom

MD, Professor Endocrinology, CHRU, Nancy, France

Professor of Medicine and University Scholar, Dept. Pathology & Molecular Medicine, Faculty of Health Sciences, McMaster University; Senior Scientist, PHRI; Director, Clinical Research Lab & Biobank-Genetic & Molecular Epidemiology Lab (CRLB-GMEL); Deputy Director, Thrombosis and Atherosclerosis Research Institute (TaARI), Hamilton, Canada

Head of Clinical Biochemistry, Department of Paediatric Laboratory Medicine, the Hospital for Sick Children, Past IFCC President, Ontario, Canada

Lecturer and Honorary Consultant, University of Exeter, Exeter, United Kingdom

Chair of Cardiovascular Genomics and Director William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London (QMUL). Fellow of The Academy of Medical Sciences in UK, London, United Kingdom

Professor of Pharmacogenetics, Erasmus MC - University Medical Center Rotterdam, The Netherlands - Director of the International (IFCC) Expertcenter for Pharmacogenetics, Rotterdam, The Netherlands

Department of Biochemistry, Faculty of Medical Sciences University of Kragujevac, Kragujevac, Serbia, Director of Center for Medical Biochemistry University Clinical Center of Serbia, Belgrade, Serbia, Founder and President of the Serbian Society for Clinical Laboratory Medicine and Science (SCLM), IFCC WG Next-Generation Technologies for Cardio-vascular Disease Prevention and Management (WG CARDIOIMPACT) Chair, ESPT Treasurer, Belgrade, Serbia

MD, Professor in Clinical Biochemistry and Clinical Molecular Biology-Head Physician of the Laboratory Medicine Unit-University of Tor Vergata Hospital, Rome, Italy

Associate Professor in Nutrigenetics and Cardiovascular Health, Queen Mary University of London, London, United Kingdom

MD, DSc. Dr.h.c. professor of medical chemistry and biochemistry, Head of Institute of Medical Biochemistry and Laboratory Medicine (from1999), President elect EFLM 2024-2025, member of Education and management Division (EMD) IFCC 2021-2025, Prague, Czech Republic

MD, Professor of Internal Medicine at the School of Medicine of Belgrade, Belgrade, Serbia

Posters/Oral Communications (OC) Committee

Director of Research in INSERM for 24 years, President of the Santorini Conferences Association (SCs) and of the “Santorini Conferences series”, Founder & Coordinator of the VEGF Consortium, Bernecourt, France

President of the Committee

Associate Professor in Nutrigenetics and Cardiovascular Health, Queen Mary University of London, London, United Kingdom

Director, R&D, Genetic Sciences Group Thermo Fisher Scientific, Santa Clara, United States

Organising Committee

Director of Research in INSERM for 24 years, President of the Santorini Conferences Association (SCs) and of the “Santorini Conferences series”, Founder & Coordinator of the VEGF Consortium, Bernecourt, France

Director of Research, R&D Digitsole, Nice, France - Post-Doc. Researcher, AI & Data Evaluation, University of Granada, Granada, Spain

MD, radiologist, Nancy, Frace

Digital Marketing Strategist

Associate Professor in Nutrigenetics and Cardiovascular Health, Queen Mary University of London, London, United Kingdom

Scientific Programme

Day 1

TUESDAY 26 MAY, 2026

2:00 pm

REGISTRATION

3:00 pm - 3:30 pm

WELCOME

Sofia Siest, Bernécourt, France  

3:30 pm - 4:15 pm

KEYNOTE LECTURE

Chair: Sofia Siest, Bernécourt, France  

Philippe Froguel, Lille, France

Unlocking Personalised Medicine in Obesity

4:15 pm – 4:45 pm

PLENARY LECTURE

Chair : Sofia Siest, Bernecourt, France

Tomris Ozben, Antalya, Turkey

Green Labs for improving environmental sustainability. What are the Priorities of Medical Laboratories in switching to Green Labs?

4:45 pm - 5:00 pm

Introduction to the CONFERENCE

Sofia Siest, Bernécourt, France 

5:00 pm - 6:30 pm

General Assembly of the Santorini Conferences (SCs) association

7:00 pm - 9:00 pm

Welcome reception at De Sol Hotel

Day 2

WEDNESDAY 27 MAY, 2026

9:00 am - 11:00 am SESSION I

Chairs: Helena Murray, Antrim, United Kingdom / Behrooz Alizadeh, Gröningen, The Netherlands 

New biomarkers/approaches in disease stratification and therapy to be taken into account in pharmacogenomics?

9:00 am - 9:30 am

Mark Ruddock, Antrim, United Kingdom 

Trauma preconditioning of cytokine response: comparison of perioperative cardiac surgery and fracture orthopaedic surgery cytokine profiles impacting AKI 

9:30 am - 10:00 am

Ioannis Papassotiriou, Athens, Greece 

Pharmacogenomics of Sickle Cell Disease Therapeutics

10:00 am - 10:30 am

Behrooz Alizadeh, Gröningen, The Netherlands 

Current approaches to multi-morbidity: A multidisciplinary task for Precision Medicine 

10:30 am – 11:00 am

Amélie Bonnefond, Lille, France  

Contribution of Rare Variants in Identifying New Therapeutic Targets  

11:00 am - 11:30 am

Coffee Break

11:30 am - 12:30 pm SESSION II

Molecular advances in therapy using vaccines  

Chairs: Federica Marelli-Berg, London, United Kingdom / Tomas Zima, Prague, Czech Republic 

11:30 am - 12:00 pm

Federica Marelli-Berg, London, United Kingdom 

Covid-19 mRNA vaccines and autoimmunity. 

12:00 pm - 12:30 pm

Eric Quemeneur, Paris, France  

Lessons learned from prophylactic vaccine design and precision vaccinology 

12:30 pm - 1:30 pm

1st dedicated poster session 

1:30 pm - 2:30 pm

🍽️ LUNCH TIME 🍽️

2:30 pm - 4:10 pm SESSION III

Clinical Relevance of Liquid Biopsy Circulating Biomarkers: Who, What, Where, When, and Why?   

Chairs: Catherine Panabieres, Montpellier, France / Alexander Haushofer, Wels, Austria  

2:30 pm - 2:50 pm

Catherine Alix-Panabières, Montpellier, France  

The biology of metastasis-competent CTCs in colon and breast cancer 

2:50 pm - 3:10 pm

Bernhard Strasser, Wels, Austria 

Circulating biomarkers – Facts and Hope (The view – Recommendations of the Austrian Society of Laboratory Medicine and Clinical Chemistry) 

3:10 pm - 3:30 pm

Silvia Rocchiccioli, Pisa, Italy 

Salivary exosomes as carriers of novel biomarkers in pancreatic cancer 

3:30 pm - 3:50 pm

Klaus Pantel, Hamburg, Germany 

Liquid biopsy-based detection and characterization of minimal residual disease in solid tumor patients: A new window of opportunity for post-adjuvant therapy 

3:50 pm - 4:10 pm

Lisa Mustafa, Salzburg, Austria 

Applications in a private lab  

4:10 pm - 5:30 pm

 SELECTED ABSTRACTS – ORAL COMMUNICATIONS SESSION  

Chairs: Stavroula Kanoni, London, United Kingdom / Enrico Iaccino, Catanzaro, Italy 

7:00 pm

Congress dinner at De Sol Hotel

Day 3

THURSDAY 28 MAY, 2026

9:00 am - 11:20 am SESSION IV

Functional tests, reference values, danger in popularisation, AI and pharmacogenomics 

Chairs: Khosrow Adeli, Toronto, Ontario, Canada / Alexander Haushofer, Wels, Austria 

9:00 am - 9:20 am

Alexander Haushofer, Wels, Austria  

PGx and functional markers in antiaggregating and anticoagulation therapies – Everything clear? 

9:20 am - 9:40 am

Khosrow Adeli, Toronto, Ontario, Canada 

Clinical Applications of Cardiac Markers in Pediatrics 

9:40 am - 10:00 am

Sanja Stankovic, Belgrad, Serbia

Decoding Lp (a): lessons of the past and prospects for the future

10:00 am - 10:20 am

Tomas Zima, Prague, Czech Republic 

Cancer screening programmes 

10:20 am - 10:40 am

Mark Ruddock, Antrim, United Kingdom 

Use of a BMI-independent biomarker-based prostate cancer risk score to identify and triage individuals at risk of prostate disease 

10:40 am - 11:00 am

Sergio Bernandini, Rome, Italy 

The Reference Values in the Precision Medicine Era: They still make sense? 

11:00 am - 11:20 am

Andrea Griesmacher, Innsbruck, Austria 

Some examples from everyday clinical practice 

11:20 am - 11:50 am

Coffee Break

11:50 am - 1:30 pm SESSION V

Predicting Disease risk – are integrated risk scores clinically useful?  

 Chairs: Behrooz Alizadeh, Gröningen, The Netherlands / Stavroula Kanoni, London, United Kingdom 

11:50 am - 12:10 pm

Stavroula Kanoni, London, United Kingdom  

The clinical utility of integrated risk scores for risk prediction – lessons learnt from CAD 

12:10 pm - 12:30 pm

Brooke N. Wolford, Trondheim, Norway  

Proteomics and genomics as risk predictors of cardiometabolic diseases 

12:30 pm - 12:50 pm

Behrooz Alizadeh, Gröningen, The Netherlands  

Predicting of mental diseases 

12:50 pm - 01:10 pm

Ammira Akil, Doha,Qatar 

ML approaches for improved T2D risk stratification in the Qatar Biobank  

1:10 pm - 1:30 pm

Richard Oram, Exeter, United Kingdom  

Use of “digital twin” simulations in healthcare, example(s) from autoimmune disease 

1:30 pm - 2:30 pm

🍽️ LUNCH TIME 🍽️

2:30 pm - 4:00 pm SESSION VI

Personalised Lifestyle as part of Precision Medicine 

Chairs: Guillaume Paré, Hamilton, Canada / Aris Eliopoulos, Athens, Greece  

2:30 pm - 3:00 pm

Guillaume Paré, Hamilton, Canada  

Precision nutrition in the era of biobank-scale studies: Using polygenic score to predict response to diet 

3:00 pm - 3:30 pm

Aristides Eliopoulos, Athens, Greece  

Brain organoids in personalized nutrition and pharmacotherapy in Obesity 

3:30 pm - 4:00 pm

Kalliopi Gkouskou, Athens, Greece  

Decoding the genetic blueprint of social eating: From empathy to obesity 

4:00 pm - 5:30 pm SESSION VII

Key progression steps forward pharmacogenomics 

Chairs: Ron Van Schaik, Rotterdam, The Netherlands / Sergio Bernandini, Rome, Italy 

4:00 pm - 4:30 pm

Ron Van Schaik, Rotterdam, The Netherlands 

Improving guidelines in pharmacogenomics 

4:30 pm - 5:00 pm

Daniel Hertz, Michigan, USA  

Developing tools for individualising cancer treatments 

5:00 pm - 5:30 pm

Jean Christophe Boyer, Nîmes, France

Predicting life-threatening fluoropyrimidine toxicity beyond DPYD testing.

5:30 pm - 6:30 pm

2nd dedicated poster session

Day 4

FRIDAY 29 MAY, 2026

9:00 am - 10:40 am SESSION VIII

Functional genomics, understanding of disease pathophysiology  

Chairs: Panos Deloukas, London, United Kingdom / Silvia Rocchiccioli, Pisa, Italy 

9:00 am - 9:20 am

Panos Deloukas, London, United Kingdom 

Advances on Cardiovascular Genomics 

9:20 am – 9:40 am

Fariba Ahmadizar, Utrecht, The Netherlands 

Integrating Multi-Omics and Biomarkers for Risk Prediction in Diabetes and Mental Health 

9:40 am - 10:00 am

Federica Marelli-Berg, London, United Kingdom 

Role of the host response in Infective Endocarditis 

10:00 am - 10:20 am

Georges Dedoussis, Athens, Greece 

Combining biomarkers in MASH diagnosis; the GRIPonMASH study 

10:20 am - 10:40 am

Alexander Haliassos, Athens, Greece 

NGS and AI in prenatal diagnosis: Issues and ethical implications 

10:40 am - 11:30 am

☕ Coffee Break ☕

 🏆🎖📜 POSTERS AWARDS ATTRIBUTION 📜🎖 🏆

11:30 am – 12:30 pm SESSION IX

4P (Prediction, Prevention, Precision and Participation) strategies for obesity and diabetes  

Chairs: Amelie Bonnefond, Lille, France / Sanja Stankovic, Belgrad, Serbia

11:30 am - 12:00 pm

Philippe Froguel, Lille, France 

4P’s strategies in diabetes 

12:00 pm - 12:30 pm

Anita Morandi, Verona, Italie 

4P’s strategies in obesity 

12:30 pm - 1:30 pm

Closing session  

Sofia Siest, Bernécourt, France 

Speakers

Director of Research in INSERM for 24 years, President of the Santorini Conferences Association (SCs) and of the “Santorini Conferences series”, Founder & Coordinator of the VEGF Consortium, Bernecourt, France

PharmD, MSc, PhD, Senior Assistant Professor, Department of Data Science and Biostatistics, University Medical Center Utrecht (UMCU), Visiting Scientist Department of Epidemiology, Harvard T.H. Chan School of Public Health, USA, Utrecht, The Nederlands

leadership role at Sidra Medicine’s Metabolic and Mendelian Clinical Genomic Research Program, Lead Principal Investigator for the Precision OMICs Research & Translational Medicine initiative in Doha, Qatar, Doha, Qatar

MD, genetic epidemiology at UMCG Groningen, CHARGE, Groningen, Gröningen, The Netherlands

Lecturer and Honorary Consultant, University of Exeter, Exeter, United Kingdom

MD, PhD, BHF Chair of Cardiovascular Immunology, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London (QMUL), London, United Kingdom

MD, Professor in Clinical Biochemistry and Clinical Molecular Biology-Head Physician of the Laboratory Medicine Unit-University of Tor Vergata Hospital, Rome, Italy

Director of Research in INSERM at the INSERM/CNRS 1283/8199-unit, Lille Pasteur Institute and University of Lille, head of team “Metabolic functional (epi)genomics and their abnormalities in type 2 diabetes and related disorders”, scientific director of the PIA-funded EquipEx LIGAN-PM platform for next-generation sequencing in precision medicine, Lille, France

University Hospital of Nîmes, France. Head of the Toxicology Unit of the Biochemistry and Molecular Biology Department. one of the founders of the French-speaking Pharmacogenetic Network (RNPGx), Nîmes, France

Professor of Molecular Genetics and Nutrigenetics at the Department of Science in Nutrition-Dietetics of Harokopio University in Athens and the Rector of the University since 09/2024, Athens, Greece

Chair of Cardiovascular Genomics and Director William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London (QMUL). Fellow of The Academy of Medical Sciences in UK, London, United Kingdom

Research Associate and Senior Physician at the Institute of Clinical Chemistry and Laboratory Medicine at Klinikum Wels-Grieskirchen in Upper Austria, Deputy Head of the Institute in Wels, Chair of Young Laboratory Medicine in the Austrian Society for Clinical Chemistry and Laboratory Medicine (ÖGLMKC), Wels, Austria

Professor of Biology & Genetics and Head of the Department of Biology at the National & Kapodistrian University of Athens (NKUA), School of Medicine. Co-founder of the NKUA spin-off company “GENOSOPHY”, Athens, Greece

MD, PhD, Professor and chair of Genomic Medicine at Imperial College London, and Professor of Endocrinology at Lille University hospital, director of the Inserm/CNRS/Pasteur/Lille University research group "Functional(epi)genomics and mechanisms of type 2 diabetes and related disorders”, Director of the European Genomic Institute for Diabetes research (EGID) and of the French National Center for Precision Medicine in diabetes PreciDIAB, Lille, France

Assistant Professor of Biology and Genetics at the Medical School of the National and Kapodistrian University of Athens (NKUA), Athens, Greece

MD, Professor at University Hospitals of Innsbruck, President of the Austrian Association for Quality Assurance and Standardization of Medical and Diagnostic Tests (ÖQUASTA), Innsbruck, Austria

MD, PhD, EurSpLM, President and CEO of DIAMEDICA PC, Scientific Director of ESEAP - Non profit Greek External Quality Assessment Scheme for Clinical Laboratories, IFCC Treasurer, Athens, Greece

MD, Head of the "Institut für Medizinische und Chemische Labordiagnostik/Central Laboratory”, Klinikum Wels-Grieskirchen, Upper Austria, Austria, Past President of the Austrian Society for Laboratory Medicine and Clinical Chemistry – ÖGLMKC, Wels, Austria

Associate Professor at the University of Michigan College of Pharmacy, Michigan, United States

Associate Professor in Clinical Biochemistry, University “Magna Graecia” of Catanzaro, Catanzaro, Italy

Associate Professor in Nutrigenetics and Cardiovascular Health, Queen Mary University of London, London, United Kingdom

Head of Clinical Biochemistry, Department of Paediatric Laboratory Medicine, the Hospital for Sick Children, Past IFCC President, Ontario, Canada

Director, R&D, Genetic Sciences Group Thermo Fisher Scientific, Santa Clara, United States

Associate Professor of Pediatrics at the University of Verona, Italy, pediatric endocrinologist and diabetologist at the University Hospital of Verona, member of the Italian Society for Pediatric Endocrinology and Diabetology (ISPED) and of the ISPED Obesity Study Group, of the EASO, the Italian Society of Obesity (SIO) and of the SIO Scientific Committee, of the European Society for Pediatric Endocrinology (ESPE) and of the European Childhood Obesity Group (ECOG), Verona, Italy

Team Leader in Molecular Diagnostics at Randox, Antrim, United Kingdom

Medical Director of Medical Diagn, Laboratory Dr. Holzer GmbH, Head of the Hematology Department and of the Molecular Biology Department at Medilab Salzburg, Salzburg, Austria

President of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and current Executive Board member of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) as Past-President, Past-President and Executive Board member of the Balkan Clinical Laboratory Federation (BCLF), Chair of the EFLM Task Force-Green and Sustainable Laboratories (TF-GSL), one of the Board of Directors of the IFCC Foundation for Emerging Nations (FEN), the FORUM Consultant of the IFCC Task Force-Young Scientists, Honorary member of the Italian Society of Clinical Chemistry and Clinical Molecular Biology (SIBioC), Slovak Society of Clinical Biochemistry (SSKB), Society of Medical Biochemists of Serbia (DMBS) and Kosova Association of Clinical Chemistry (KACC), supervisor for the Doctorate Program entitled “Clinical and Experimental Medicine” at the Medical Faculty, University of Modena and Reggio Emilia, Italy, an external examiner for the Post-graduate Master and Ph.D. education at the University of Zimbabwe, College of Health Sciences, Department of Chemical Pathology, Antalya, Turquey

MD, Professor in Oncology, Faculty of Medicine, Director of the Liquid Biopsy Laboratory, CHU, Montpelier, France

Dr. med. Professor, Director, Institute of Tumor Biology at Universitätsklinikum Hamburg-Eppendorf, Hambourg, Germany

PhD, EuSpLM, Director of the Department of Clinical Biochemistry of “Aghia Sophia” Children’s Hospital, Athens, Greece, and researcher in First Department of Pediatrics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Professor of Medicine and University Scholar, Dept. Pathology & Molecular Medicine, Faculty of Health Sciences, McMaster University; Senior Scientist, PHRI; Director, Clinical Research Lab & Biobank-Genetic & Molecular Epidemiology Lab (CRLB-GMEL); Deputy Director, Thrombosis and Atherosclerosis Research Institute (TaARI), Hamilton, Canada

PharmD, Previously, excecutive vice-President in TRANSGENE, currently, Inserm - leader of France Vaccins, Paris, France

Senior Researcher of Italian National Research Council, Rome – CNR, Pisa, Italy

PhD, Clinical Studies and Development Manager at Randox Laboratories Ltd, Antrim, UK, Occasional Lecturer at Queens University Belfast, Belfast, United Kingdom

Professor of Pharmacogenetics, Erasmus MC - University Medical Center Rotterdam, The Netherlands - Director of the International (IFCC) Expertcenter for Pharmacogenetics, Rotterdam, The Netherlands

Department of Biochemistry, Faculty of Medical Sciences University of Kragujevac, Kragujevac, Serbia, Director of Center for Medical Biochemistry University Clinical Center of Serbia, Belgrade, Serbia, Founder and President of the Serbian Society for Clinical Laboratory Medicine and Science (SCLM), IFCC WG Next-Generation Technologies for Cardio-vascular Disease Prevention and Management (WG CARDIOIMPACT) Chair, ESPT Treasurer, Belgrade, Serbia

PhD in Bioinformatics and Master in Statistics from the University of Michigan, Marie Skłodowska-Curie Postdoctoral Fellow in the HUNT Center for Molecular and Clinical Epidemiology at the Norwegian University of Science and Technology, Trondheim, Norway

MD, DSc. Dr.h.c. professor of medical chemistry and biochemistry, Head of Institute of Medical Biochemistry and Laboratory Medicine (from1999), President elect EFLM 2024-2025, member of Education and management Division (EMD) IFCC 2021-2025, Prague, Czech Republic

❤️

You will Fall in 'Science' at Santorini! .

📢 Call for Poster/Oral Communication

Authors are invited to submit their abstracts under one of the following categories:

📌 Poster Presentation
🎤 Oral Communication (Limited number)

✅ Evaluation Criteria

Each submission will be assessed based on the following:

Originality & Relevance – The topic’s novelty and its significance in the field.
Scientific Rigor – Meaningful interpretation of results.
Presentation Quality – Clarity, structure, and attractiveness of the abstract.

🏆 Awards & Recognition

The two Best posters will be awarded the prestigious Gérard SIEST Poster Award (500 € each)

These awards will be granted based on scientific quality and relevance, as evaluated by the Posters Committee.

📖 Publication Opportunity:
All accepted abstracts will be published online.

📌 Abstracts Submission

The presenting author must be registered for the conference with either Full or Student Registration.
There is no limit to the number of abstracts a registered author can submit.

📌 Posters Preparation Instructions

Auspices,Sponsors & Supports

Auspices, Sponsorship and Support play a vital role in the success of our event, enabling us to bring together experts, researchers, and professionals from around the world. By partnering with organisations that share our vision, we ensure the highest quality of discussions, networking opportunities, and scientific advancements. These contributions not only enhance the conference experience but also foster innovation and collaboration in the field.

We are grateful for the commitment of our sponsors and supporters, whose contributions make this event possible.

Auspices

Sponsors

🌟Platinum

🥇 Gold

🥈 Silver

🥉 Bronze

🔹 Other Sponsorship

Sponsorship Levels

Our sponsorship levels are designed to provide organisations with tailored opportunities for visibility, networking, and engagement. Each level offers unique benefits, allowing sponsors to align their support with their strategic goals while contributing to the success of the event.

Below is an overview of the available Sponsorship levels.

Supports

Support refer to National Societies, non-profit Associations and other organisations that financially support or contribute resources to the event. These supports play a crucial role in funding and promoting Conference initiatives.

The level of the support should be discussed with the scientific organiser of the conference: sophie.siest@gmail.comPhone: 00 33 (0) 6 07 60 25 69. 

Secure Your Spot at the Forefront of Innovation

Registration Fees

Registration Fees & Benefits

Join us at the Santorini Conference and be part of a unique gathering of experts, researchers, and professionals. Our registration fees include access to all conference sessions, networking opportunities, and exclusive social events.

Early Bird Fees (until February 28th, 2026)

Don’t miss the chance to be part of this inspiring event—register now to take advantage of early bird rates!

During the Conference we will take photos and videos that will be used for the Conference’s social media communication. Please, if you have a concern inform us by email to: sophie.siest@gmail.com

Full Registration

Fabulously planned
750
What’s Included?
✔ Entrance to plenary lectures, symposia, educational workshops, poster sessions, and exhibitions
✔ Opportunity to submit abstracts
✔ Certificate of attendance
✔ Coffee and tea service during intermissions
✔2 Lunches
✔ Access to social events:
✔ Welcome Ceremony (Tuesday 26 MAY, 2026)
✔ Congress Dinner (Wednesday 27 May, 2026)

 

Students

Promoted
350
What’s Included?
✔ Entrance to plenary lectures, symposia, educational workshops, poster sessions, and exhibitions
✔ Opportunity to submit abstracts
✔ Certificate of attendance
✔ Coffee and tea service during intermissions
✔2 Lunches
✔ Access to social events:
✔ Welcome Ceremony (TUESDAY 26 MAY, 2026)
✔ Congress Dinner (Wednesday 27 May, 2026)

 

 

Accompanying Person

Join Together!
350
What’s Included?
✔ Entrance to plenary lectures, symposia, educational workshops, poster sessions, and exhibitions
✔ Certificate of attendance
✔ Coffee and tea service during intermissions
✔2 Lunches
✔ Access to social events:
✔ Welcome Ceremony (TUESDAY 26 MAY, 2026)
✔ Congress Dinner (Wednesday 27 May, 2026)

 

 

🛡️ Secure Payment Options

Credit Card or Bank Transfer

Preferred Payment Method: Online with Credit Card

💳 Credit Card Payment Process

1
2
3
4
1
2
3
4

📦 Select Your Registration Fees Package

Choose the registration package that best suits your status.

📋 Enter Your Personal Information

Fill in the required fields with your personal details. Ensure all information is accurate for a smooth registration process.

✅ Review & Confirm

Double-check your details before proceeding. Ensure your name, email, and registration package selection are correct.

💳 Complete Payment

Payment Method: ONLY with Credit Card. All transactions are encrypted and securely processed through our banking partner. Once payment is completed, you will receive a confirmation email with your registration details.

💰 Bank Transfer Payment Process

Ensure to include your full name in the transfer description.
1
2
3
4
1
2
3
4

📦 Select Your Registration Fees Package

Choose the registration package that best suits your status.

🏦 Complete the Payment via Bank Transfer

Transfer the registration fee to the provided bank account details. Ensure to include your full name and reference number in the transfer description.

📋 Enter Your Personal Information

Fill in the required fields with your personal details. Ensure all information is accurate for a smooth registration process.

📄 Upload Proof of Payment

Submit your bank transfer receipt (PDF or screenshot) via the provided upload link to confirm your payment.

Remittance

  • On-Site Registration: Payments on-site can only be made by credit card Online. Cash and cheques will not be accepted.
  • Payments fees after 30 january 2026 will be applied.

Currency

All registration fees and associated charges must be paid in euros (€).

Invoicing and name changing

When filling out the online registration form, please pay close attention to the Invoicing section to ensure accuracy.

Before registering, confirm the correct invoice details, including:

  • Invoice recipient (company or individual)
  • Billing address
  • VAT code (if applicable)
  • Fiscal code (for Italian participants only)
  • PO number (if required)

Important: Invoice details and name spelling cannot be modified after submission, so please double-check all information before proceeding.

Liability and insurance

Registration fees do not include insurance coverage for:

  • Personal accidents or medical emergencies
  • Registration cancellation by any party
  • Theft, loss, or damage to personal belongings

Recommendation: Participants are strongly advised to arrange adequate personal insurance covering travel, accommodation, cancellations, and personal effects.

Previous Conferences

10+1 Santorini Confernece

Systems Medicine, Personalised Health and Therapy. The Odyssey from Hope to Practice: “Patient first – keep Ithaca always in your mind

 

👉 Overview of The 10+1 Santorini Conference

21-24 May 2024

The 10th Santorini conference

Systems Medicine, Personalised Health and Therapy. The Odyssey from Hope to Practice: “Patient first – keep Ithaca always in your mind
23-26 May 2022

The 9th Santorini Conference

Systems Medicine, Personalised Health and Therapy. The Odyssey from Hope to Practice: “Patient first – keep Ithaca always in your mind
1-4 October 2018

8th Santorini Conference

Systems medicine and personalised health and therapy.

3-5 October 2016

Ulysses: The trip of Personalised Medicine

Poppy: In honor of Gerard SIEST

F.A.Q. .

How to reach Santorini?

So…you just landed at the Athens Airport “El.Venizelos” and you desperately want to go to Santorini.

You have 2 options to go from Athens to Santorini:
  • By plane

    That’s obviously the quickest and most expensive option. It takes about 40-45 minutes by plane to be at Santorini’s small airport and it definitely worths it in our opinion. The following companies operate direct flights from Athens to Santorini: 1. Aegean Airlines   (proposed) 2. Ryanair 3. Volotea

Fly directly to Santorini from other European cities (especially between April-October): Niki (from Vienna) Thomas Cook (from Birmingham, Gatwick, Manchester, Brussels) Thomson (from Birmingham, Gatwick, Manchester, Bristol) Volotea (from Venice, Bari, Naples, Palermo) Germanwings (from Cologne) Norwegian (from Oslo, Copenhagen, Stockholm) Transavia (from Paris, British Airways (from London Heathrow) Condor (from Munich, Hamburg, Stuttgard,, Dusseldorf, Franfurt) Aegean (from Moscow) Easyjet (from Rome, Milan, Geneva, Manchester, Gatwick) Vueling (from Barcelona, Bilbao) Jetairfly (from Brussels) HolidayJet (from Zurich)

  • By ferry

You have to go to the Athens ferry port which is called Piraeus. The easiest and cheapest option is by taking the bus hat stops just outside of the Athens airport. It takes between 50 mins to 80 mins (depending on the traffic). The bus runs 24/7 and there is a bus every 30 mins. 

How to reach the De Sol Hotel?

From the airport you can take a taxi or take a private shuttle or a local bus or you can rent a car. taxis : 0030 22860 02 2555 or 0030 22860 03 3951. At last you can rent a car for a day or your full stay at a nice price.

Rent a car online in Santorini?

Car Rentals
You can choose from a wide range of categories and brands. All our cars go through regular inspections and are all in excellent condition. Our fleet includes cars with automatic transmission too.

Our recomendation is Romani Cars.

Contact info: info@romani.gr

Touring the island by motorbike is a popular choice for holiday makers. Economical, easy to park and capable of navigating most of Santorini’s volcanic terrain. Fira the capital and other prominent villages on the island have free public parking areas. Use them to avoid traffic congestion and parking fines.From the other hand, you are advised not to hire motorcycles, scooters, mopeds or quad bikes, as accidents involving these forms of transport are very common.

Contact

Sofia SIEST

-President of the Santorini Conferences (SCs) association – For Research Innovation in Health

-President of the Santorini Conferences series

Tel.: +33 (0) 6 07 60 25 69
Email: sophie.siest@gmail.com

 

Elisavet Kokoni
Tel.: +33 (0) 7 66 80 63 37
Email: eliz@marketinggenie.fr

 

Alexandros Petrelis
Tel.: +33 (0) 6 95 86 92 09
Email: apetrelis@live.com

Newsletter

Stay ahead with the latest news, exclusive updates, and valuable insights by subscribing to our newsletter!

Why Subscribe?

✔ Get first-hand updates on new offerings, events, and special announcements.
✔ Receive expert insights, tips, and relevant content straight to your inbox.
✔ Be part of an engaged community and never miss out on important information.

Signing up is quick and easy—just click the link below and stay connected!

Contact us

Find us in Google maps

Address

De Sol Hotel & Spa, Santorini 84700, Grece

Email

info@santoriniconference.org

CONTACT

Sofia SIEST
-President of the Santorini Conferences (SCs) association – For Research Innovation in Health
-President of the Santorini Conferences series Tel.: +33 (0) 6 07 60 25 69
Email: sophie.siest@gmail.com

Elisavet Kokoni
Tel.: +33 (0) 7 66 80 63 37
Email: eliz@marketinggenie.fr

Alexandros Petrelis
Tel.: +33 (0) 6 95 86 92 09
Email: apetrelis@live.com

📩 We are Here to Help – Contact Us

Loading